The 14 most recent market catalysts affecting $QSI, each scored for sentiment and estimated stock impact. Sourced from SEC EDGAR filings and financial news, analysed automatically as they are published.
Nov 18, 2026
Corporate Catalyst
Bullish
Impact 65
Quantum-Si Demonstrates Detection of All 20 Naturally Occurring Amino Acids
Quantum-Si announced a significant technical achievement: the detection of all 20 naturally occurring amino acids in its Proteus development program, two years ahead of its 2026 ta…
Nov 6, 2026
Corporate Catalyst
Bearish
Impact 85
Quantum-Si Reports Third Quarter 2026 Financial Results
Quantum-Si's Q3 2026 results show a substantial revenue miss, down from the prior year, directly linked to customers postponing purchases for the Proteus platform. The critical new…
Oct 16, 2026
Corporate Catalyst
Neutral
Impact 75
Quantum-Si To Provide Business Update And Report Q3 2026 Results On November 5
The announcement of Quantum-Si's Q3 2026 results and business update is a significant corporate catalyst. Investors will be scrutinizing revenue growth, profitability, and any upda…
Oct 15, 2026
Corporate Catalyst
Neutral
Impact 65
Quantum-Si Receives Notice Of Compliance With Nasdaq's Minimum Bid Price Requirement
This headline signifies that Quantum-Si (QSI) has successfully met Nasdaq's minimum bid price requirement, thereby avoiding potential delisting. This is a positive development for …
Oct 9, 2026
Corporate Catalyst
Bullish
Impact 75
Quantum-Si shares are trading higher after the company announced that it has demonstrated detection of 19 amino acids in its Proteus development program.
This headline represents a significant corporate catalyst for Quantum-Si (QSI). Demonstrating the detection of 19 amino acids is a crucial technical milestone for their Proteus dev…
Oct 9, 2026
Market Technicals
Bullish
Impact 55
12 Health Care Stocks Moving In Friday's Intraday Session
This Benzinga article, presented as an 8-K filing, details the intraday performance of 12 health care stocks. It's a snapshot of market activity, not a disclosure of specific corpo…
Oct 8, 2026
Corporate Catalyst
Neutral
Impact 75
Quantum-Si Demonstrates Detection of 19 Amino Acids in Proteus Development Program; Co Is Now Working To Deploy That Capability Into A Developmental Sequencing Kit For Routine Use On Integrated Proteus Instruments
Quantum-Si announced a key technical achievement in its Proteus development program, successfully demonstrating the detection of 19 amino acids. This is a crucial step towards thei…
Oct 5, 2026
Market Technicals
Bearish
Impact 65
Top 3 Health Care Stocks That May Collapse In Q4
The filing identifies Quantum-Si (QSI), Kodiak Sciences (KOD), and Iovance Biotherapeutics (IOVA) as healthcare stocks with RSI values significantly above 70, indicating they are o…
Sep 29, 2026
Corporate Catalyst
Bullish
Impact 75
Why Is Quantum-Si Stock Gaining Tuesday?
Quantum-Si's stock surged over 24% after presenting interim data for its Proteus platform at HUPO 2026, showcasing a 'step-change' in performance compared to its predecessor, Plati…
Sep 29, 2026
Corporate Catalyst
Bullish
Impact 75
Quantum-Si shares are trading higher after the company announced interim development results comparing its next-generation Proteus platform with its commercially available Platinum Pro instrument. Also, HC Wainwright & Co. reiterated its Buy rating and maintained a $4 price target on the stock.
The headline indicates a strong positive corporate catalyst for Quantum-Si. The interim development results for their Proteus platform, showing superiority to their current commerc…
Sep 29, 2026
Corporate Catalyst
Neutral
Impact 55
HC Wainwright & Co. Reiterates Buy on Quantum-Si, Maintains $4 Price Target
This 8-K filing discloses that HC Wainwright & Co. analyst Swayampakula Ramakanth has reiterated a 'Buy' rating on Quantum-Si (QSI) and maintained a $4 price target. This is not ne…
Sep 29, 2026
Corporate Catalyst
Bullish
Impact 75
Reported Earlier, Quantum-Si's Proteus Significantly Outperforms Platinum Pro Across Every Key Measure In Interim Development Results Using 18-Amino-Acid Kit, Launch Expected In Second Quarter Of 2027
This headline is a significant corporate catalyst for Quantum-Si (QSI), indicating strong progress in their Proteus platform. The 'significantly outperforms' language suggests a co…
Aug 13, 2026
Corporate Catalyst
Bearish
Impact 75
Quantum-Si Announces Reduction In Force Of ~ 20% Of Workforce
Quantum-Si announced a significant reduction in force, cutting approximately 20% of its workforce. This decision was made to realign resources and spending due to an updated, presu…
Aug 13, 2026
Corporate Catalyst
Bullish
Impact 75
Quantum-Si Q2 EPS $(0.11) Beats $(0.12) Estimate, Sales $344.000K Beat $302.000K Estimate
Quantum-Si (QSI) announced its Q2 earnings, reporting a smaller loss per share than anticipated and sales that exceeded analyst expectations. This indicates a positive surprise for…
Not financial advice. AI-generated analysis for informational purposes only. Tradow AI LLC is not a registered investment adviser.